PPARG and metabolic dysfunction-associated steatotic liver disease: miR-155 activity is reduced by adipogenic transcription factors CCAAT/enhancer-binding protein (C/EBP)-α, C/EBP-β, PPAR-γ, and LXRα in NAFLD patients; further, miR-155 is implicated in carcinogenesis in NAFLD [84,85,86].